Citation:Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, et al 2011

From Cancer Guidelines Wiki

Citation


Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, et al. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil Steril 2011 Mar 1;95(3):906-14.e1-4 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21145541.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Ovarian suppression during chemotherapyDr Wanyuan Cui MBBS BMEDSCI FRACPcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. AYA cancer fertility preservation/Options for fertility preservation/Ovarian suppression with GnRH analogues during chemotherapy